Trials / Conditions / Maroteaux-Lamy Syndrome
Maroteaux-Lamy Syndrome
6 registered clinical trials studyying Maroteaux-Lamy Syndrome.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome NCT02156674 | Masonic Cancer Center, University of Minnesota | N/A |
| Active Not Recruiting | MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis NCT02171104 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Completed | Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy NCT01961518 | Greenwood Genetic Center | — |
| Completed | Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders NCT01043640 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Terminated | Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism NCT00668564 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Completed | A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI NCT00299000 | BioMarin Pharmaceutical | Phase 4 |